In a lab in Houghton, Michigan, a heart is beating that has never taken a breath.

It is not alive. It is a working replica, built layer by layer from a real patient’s own anatomy. Inside Michigan Technological University’s Biofluids Laboratory, researchers pump blood analogs through these 3D-printed silicone models, then track every particle moving through them with lasers, searching for the exact spot where a dangerous clot would form.

The lab is led by Hoda Hatoum, an associate professor of biomedical engineering, and one of its current federal grants targets Kawasaki disease. The condition inflames the coronary arteries of young children and can leave behind aneurysms, areas of the artery that balloon outward and become prone to dangerous blood clots. For decades, doctors have relied on a single measurement, called a z-score, to judge how risky an aneurysm might be. It is a reasonable starting point, but it does not capture how blood actually moves through a uniquely shaped, uniquely damaged artery.

That is the gap Hatoum’s team is working to close. In published work on how blood moves through these damaged arteries, the lab has already shown that hemodynamics, not size alone, shapes clotting risk. Using a custom-built pulse duplicator designed to recreate the rhythm and pressure of a real heartbeat, they run patient-specific models through thousands of simulated heartbeats, mapping where blood slows, swirls or stagnates in ways that invite clotting.

The implications reach beyond Kawasaki disease. The same lab studies other congenital heart defects, and the same core idea, building the patient’s heart before operating on the patient, has an obvious next chapter: a surgeon rehearsing a delicate repair on an exact copy of a child’s heart, working out the hardest decisions on silicone before ever picking up a scalpel.

None of this has reached a patient yet. It may be years before it does. But that has always been true of research at this stage. A heart pump, a vaccine, a cancer drug, a dissolving surgical implant: every one of them looked, at some point, like a machine in a lab running tests nobody outside the building understood yet.

That is what a federal grant buys in Houghton. Not a finished cure, but the years of unglamorous, exacting work that make a finished cure possible. Cut that funding and you do not just delay a technology. You risk losing very specific expertise: the pulse duplicators, the particle-tracking lasers and the clinical partnerships that took a generation to build and cannot be reassembled overnight.

Michigan’s research universities are not a cost the state absorbs. They are where the next generation of medicine is quietly, patiently being built, one artificial heartbeat at a time.

Michigan’s research universities are also an economic engine, generating $51.4 billion in annual economic activity, 7.1% of the state’s GDP. A call for cuts to university research is a call to cut the lifesaving discoveries and the economic benefits Michigan residents have relied on for generations.

Discover how Michigan’s research universities are solving real problems across the state:

Michigan State University: https://msu.edu/researchforyou

Michigan Technological University: https://www.mtu.edu/research/

University of Michigan: https://looktomichigan.umich.edu/

Wayne State University: https://wayne.edu/research-impact